Literature DB >> 11006479

Pathogenesis of malaria.

I A Clark1, L Schofield.   

Abstract

As the mortality rate of 20-30% for severe falciparum malaria under even the best clinical conditions testifies, access to antimalarial drugs is not sufficient to prevent an appreciable mortality from this disease. Understanding the cause of death at a cellular level is essential if additional rational treatments are to be developed. Here, Ian Clark and Louis Schofield discuss recent work presented at the Molecular Approaches to Malaria conference, Lorne, Australia, 2-5 February 2000, that updates the cytokine-based concept of malarial disease.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11006479     DOI: 10.1016/s0169-4758(00)01757-9

Source DB:  PubMed          Journal:  Parasitol Today        ISSN: 0169-4758


  27 in total

1.  The purine salvage enzyme hypoxanthine guanine xanthine phosphoribosyl transferase is a major target antigen for cell-mediated immunity to malaria.

Authors:  Morris O Makobongo; George Riding; Huji Xu; Chakrit Hirunpetcharat; Dianne Keough; John de Jersey; Peter Willadsen; Michael F Good
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-19       Impact factor: 11.205

Review 2.  Cytokines in the pathogenesis of and protection against malaria.

Authors:  Iñigo Angulo; Manuel Fresno
Journal:  Clin Diagn Lab Immunol       Date:  2002-11

Review 3.  Recent trends on hydrogel based drug delivery systems for infectious diseases.

Authors:  Arti Vashist; Ajeet Kaushik; Atul Vashist; Rahul Dev Jayant; Asahi Tomitaka; Sharif Ahmad; Y K Gupta; Madhavan Nair
Journal:  Biomater Sci       Date:  2016-10-18       Impact factor: 6.843

Review 4.  Natural regulatory T cells in malaria: host or parasite allies?

Authors:  Diana S Hansen; Louis Schofield
Journal:  PLoS Pathog       Date:  2010-04-29       Impact factor: 6.823

5.  Cellular tumor necrosis factor, gamma interferon, and interleukin-6 responses as correlates of immunity and risk of clinical Plasmodium falciparum malaria in children from Papua New Guinea.

Authors:  Leanne J Robinson; Marthe C D'Ombrain; Danielle I Stanisic; Jack Taraika; Nicholas Bernard; Jack S Richards; James G Beeson; Livingstone Tavul; Pascal Michon; Ivo Mueller; Louis Schofield
Journal:  Infect Immun       Date:  2009-04-20       Impact factor: 3.441

6.  Cytokine profiles and antibody responses to Plasmodium falciparum malaria infection in individuals living in Ibadan, southwest Nigeria.

Authors:  Nnaemeka C Iriemenam; Christian M F Okafor; Halima A Balogun; Idowu Ayede; Yusuf Omosun; Jan-Olov Persson; Margareta Hagstedt; Chiaka I Anumudu; Roseangela I Nwuba; Marita Troye-Blomberg; Klavs Berzins
Journal:  Afr Health Sci       Date:  2009-06       Impact factor: 0.927

Review 7.  Virulence in malaria: an evolutionary viewpoint.

Authors:  Margaret J Mackinnon; Andrew F Read
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2004-06-29       Impact factor: 6.237

Review 8.  How might infant and paediatric immune responses influence malaria vaccine efficacy?

Authors:  A M Moormann
Journal:  Parasite Immunol       Date:  2009-09       Impact factor: 2.280

Review 9.  The eye in cerebral malaria: what can it teach us?

Authors:  Richard J Maude; Arjen M Dondorp; Abdullah Abu Sayeed; Nicholas P J Day; Nicholas J White; Nicholas A V Beare
Journal:  Trans R Soc Trop Med Hyg       Date:  2008-12-18       Impact factor: 2.184

10.  The murine cerebral malaria phenomenon.

Authors:  Nicholas J White; Gareth D H Turner; Isabelle M Medana; Arjen M Dondorp; Nicholas P J Day
Journal:  Trends Parasitol       Date:  2009-11-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.